MaaT033 capsule

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in NSCLC (Advanced Non-small Cell Lung Cancer)

Drug Information

Target Indication

NSCLC (Advanced Non-small Cell Lung Cancer)

Clinical Trial

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

MAAT.PA

MAAT Pharma

Related Pipeline

Acute Graft Versus Host Disease in Intestine

Leukemia, Myeloid, Acute

Transplant Complication

Fecal Microbiota Transplantation

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts